Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017

Kailey Urban; Colleen Payton; Blain Mamo; Hannah Volkman; Katherine Giorgio; Lori Kennedy; Yuli Chen Bomber; Kristine Knuti Rodrigues; Janine Young; Carol Tumaylle; Jasmine Matheson; Azadeh Tasslimi; Jessica Montour; Emily Jentes

doi:10.1007/s10903-023-01471-8

Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017

Kailey Urban, Colleen Payton, Blain Mamo, Hannah Volkman, Katherine Giorgio, Lori Kennedy, Yuli Chen Bomber, Kristine Knuti Rodrigues, Janine Young, Carol Tumaylle, Jasmine Matheson, Azadeh Tasslimi, Jessica Montour, Emily Jentes

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Six refugee screening sites collaborated to estimate the prevalence of hepatitis C virus (HCV) antibodies among newly arrived refugees in the United States from 2010 to 2017, identify demographic characteristics associated with HCV antibody positivity, and estimate missed HCV antibody-positive adults among unscreened refugees. We utilized a cross-sectional study to examine HCV prevalence among refugees (N = 144,752). A predictive logistic regression model was constructed to determine the effectiveness of current screening practices at identifying cases. The prevalence of HCV antibodies among the 64,703 refugees screened was 1.6%. Refugees from Burundi (5.4%), Moldova (3.8%), Democratic Republic of Congo (3.2%), Burma (2.8%), and Ukraine (2.0%) had the highest positivity among refugee arrivals. An estimated 498 (0.7%) cases of HCV antibody positivity were missed among 67,787 unscreened adults. The domestic medical examination represents an opportunity to screen all adult refugees for HCV to ensure timely diagnosis and treatment.

Original language	English (US)
Pages (from-to)	1323-1330
Number of pages	8
Journal	Journal of Immigrant and Minority Health
Volume	25
Issue number	6
DOIs	https://doi.org/10.1007/s10903-023-01471-8
State	Published - Dec 2023
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2023, The Author(s).

Keywords

Hepatitis C
Immigrants
Refugee Health
Screening

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1007/s10903-023-01471-8

Find It

Find It at U of M Libraries

Cite this

Urban, K., Payton, C., Mamo, B., Volkman, H., Giorgio, K., Kennedy, L., Bomber, Y. C., Rodrigues, K. K., Young, J., Tumaylle, C., Matheson, J., Tasslimi, A., Montour, J., & Jentes, E. (2023). Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017. Journal of Immigrant and Minority Health, 25(6), 1323-1330. https://doi.org/10.1007/s10903-023-01471-8

Urban, K, Payton, C, Mamo, B, Volkman, H, Giorgio, K, Kennedy, L, Bomber, YC, Rodrigues, KK, Young, J, Tumaylle, C, Matheson, J, Tasslimi, A, Montour, J & Jentes, E 2023, 'Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017', Journal of Immigrant and Minority Health, vol. 25, no. 6, pp. 1323-1330. https://doi.org/10.1007/s10903-023-01471-8

@article{4da3fa7aa8aa472e9a4d77b14615ffba,

title = "Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017",

abstract = "Six refugee screening sites collaborated to estimate the prevalence of hepatitis C virus (HCV) antibodies among newly arrived refugees in the United States from 2010 to 2017, identify demographic characteristics associated with HCV antibody positivity, and estimate missed HCV antibody-positive adults among unscreened refugees. We utilized a cross-sectional study to examine HCV prevalence among refugees (N = 144,752). A predictive logistic regression model was constructed to determine the effectiveness of current screening practices at identifying cases. The prevalence of HCV antibodies among the 64,703 refugees screened was 1.6%. Refugees from Burundi (5.4%), Moldova (3.8%), Democratic Republic of Congo (3.2%), Burma (2.8%), and Ukraine (2.0%) had the highest positivity among refugee arrivals. An estimated 498 (0.7%) cases of HCV antibody positivity were missed among 67,787 unscreened adults. The domestic medical examination represents an opportunity to screen all adult refugees for HCV to ensure timely diagnosis and treatment.",

keywords = "Hepatitis C, Immigrants, Refugee Health, Screening",

author = "Kailey Urban and Colleen Payton and Blain Mamo and Hannah Volkman and Katherine Giorgio and Lori Kennedy and Bomber, {Yuli Chen} and Rodrigues, {Kristine Knuti} and Janine Young and Carol Tumaylle and Jasmine Matheson and Azadeh Tasslimi and Jessica Montour and Emily Jentes",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1007/s10903-023-01471-8",

language = "English (US)",

volume = "25",

pages = "1323--1330",

journal = "Journal of Immigrant and Minority Health",

issn = "1557-1912",

publisher = "Springer New York",

number = "6",

}

TY - JOUR

T1 - Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017

AU - Urban, Kailey

AU - Payton, Colleen

AU - Mamo, Blain

AU - Volkman, Hannah

AU - Giorgio, Katherine

AU - Kennedy, Lori

AU - Bomber, Yuli Chen

AU - Rodrigues, Kristine Knuti

AU - Young, Janine

AU - Tumaylle, Carol

AU - Matheson, Jasmine

AU - Tasslimi, Azadeh

AU - Montour, Jessica

AU - Jentes, Emily

PY - 2023/12

Y1 - 2023/12

N2 - Six refugee screening sites collaborated to estimate the prevalence of hepatitis C virus (HCV) antibodies among newly arrived refugees in the United States from 2010 to 2017, identify demographic characteristics associated with HCV antibody positivity, and estimate missed HCV antibody-positive adults among unscreened refugees. We utilized a cross-sectional study to examine HCV prevalence among refugees (N = 144,752). A predictive logistic regression model was constructed to determine the effectiveness of current screening practices at identifying cases. The prevalence of HCV antibodies among the 64,703 refugees screened was 1.6%. Refugees from Burundi (5.4%), Moldova (3.8%), Democratic Republic of Congo (3.2%), Burma (2.8%), and Ukraine (2.0%) had the highest positivity among refugee arrivals. An estimated 498 (0.7%) cases of HCV antibody positivity were missed among 67,787 unscreened adults. The domestic medical examination represents an opportunity to screen all adult refugees for HCV to ensure timely diagnosis and treatment.

AB - Six refugee screening sites collaborated to estimate the prevalence of hepatitis C virus (HCV) antibodies among newly arrived refugees in the United States from 2010 to 2017, identify demographic characteristics associated with HCV antibody positivity, and estimate missed HCV antibody-positive adults among unscreened refugees. We utilized a cross-sectional study to examine HCV prevalence among refugees (N = 144,752). A predictive logistic regression model was constructed to determine the effectiveness of current screening practices at identifying cases. The prevalence of HCV antibodies among the 64,703 refugees screened was 1.6%. Refugees from Burundi (5.4%), Moldova (3.8%), Democratic Republic of Congo (3.2%), Burma (2.8%), and Ukraine (2.0%) had the highest positivity among refugee arrivals. An estimated 498 (0.7%) cases of HCV antibody positivity were missed among 67,787 unscreened adults. The domestic medical examination represents an opportunity to screen all adult refugees for HCV to ensure timely diagnosis and treatment.

KW - Hepatitis C

KW - Immigrants

KW - Refugee Health

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85151381665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85151381665&partnerID=8YFLogxK

U2 - 10.1007/s10903-023-01471-8

DO - 10.1007/s10903-023-01471-8

M3 - Article

C2 - 36995524

AN - SCOPUS:85151381665

SN - 1557-1912

VL - 25

SP - 1323

EP - 1330

JO - Journal of Immigrant and Minority Health

JF - Journal of Immigrant and Minority Health

IS - 6

ER -

Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this